Wyndham Hotels & Resorts announced that its Trademark Collection brand now has more than 100 properties in the United States, marking the first time the soft‑brand has crossed the 100‑property threshold. The announcement was made on March 16 2026.
The milestone reflects a doubling of the U.S. portfolio over the past five years, from roughly 50 properties in 2021 to 100+ today. The rapid expansion is driven by independent hotel owners who value Wyndham’s global distribution and loyalty program while preserving their local identity.
The growth adds to Wyndham’s franchise footprint, potentially increasing fee‑related revenue. The company’s 2026 guidance projects fee‑related revenues of $1.46‑$1.49 billion, and the addition of 100+ properties is expected to contribute a meaningful share of that stream.
The Trademark Collection’s success comes amid a broader competitive landscape where other soft‑brands are also expanding. Wyndham’s focus on the economy and midscale segments, combined with its asset‑light franchising model, positions it to capture market share from both traditional brands and newer entrants.
Management highlighted the brand’s appeal: “The Trademark Collection allows independent owners to keep what makes their hotels special while tapping into the power of Wyndham.” The milestone underscores the company’s strategy to grow through partnerships with independent operators rather than through new construction.
While the milestone is a positive sign, Wyndham’s overall financial picture remains mixed. In Q4 2025, the company beat earnings expectations by $0.03 per share, but revenue fell short of forecasts by $3.5 million. The company’s FY 2026 EPS guidance of $4.62‑$4.80 is below analyst consensus, reflecting a cautious outlook amid debt levels and a low Altman Z‑Score.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.